Song, Gaojie
Yang, Dehua
Wang, Yuxia
de Graaf, Chris
Zhou, Qingtong
Jiang, Shanshan
Liu, Kaiwen
Cai, Xiaoqing
Dai, Antao
Lin, Guangyao
Liu, Dongsheng
Wu, Fan
Wu, Yiran
Zhao, Suwen
Ye, Li
Han, Gye Won
Lau, Jesper
Wu, Beili
Hanson, Michael A.
Liu, Zhi-Jie
Wang, Ming-Wei
Stevens, Raymond C.
Article History
Received: 9 January 2017
Accepted: 20 April 2017
First Online: 17 May 2017
Competing interests
: J.L. is an employee of Novo Nordisk, a pharmaceutical company focused on GLP-1R for type 2 diabetes. R.C.S. is a founder and board member of Bird Rock Bio, a company focused on GPCR therapeutic antibodies. The remaining authors declare no competing financial interests.